Takeda spinout Phathom clinches FDA twin nods for GI infection combos—plus timely capital infusion
Takeda spinout Phathom clinches FDA twin nods for GI infection [...]
Takeda spinout Phathom clinches FDA twin nods for GI infection [...]
Amarin, after 33% revenue decline, aims to ‘stabilize’ US sales [...]
Bayer’s Nubeqa one step closer to blockbuster status thanks to [...]
Teva settlement prevents Lupin from launching its Austedo generic until [...]
With FDA approval, Supernus’ Qelbree is the first nonstimulant ADHD [...]
Emergent mourns passing of founder and former CEO El-Hibri just [...]
AbbVie’s red-hot Rinvoq scores fourth FDA approval in five months [...]
Pfizer loses top vaccine scientist Jansen who led drive for [...]
Novo’s Wegovy supply rebound on track for later this year [...]
Amid legal tumult, J&J shareholders reject proposal to end talc [...]